RETRACTED: Effect of Previous Cancer History on Survival of Patients with Different Subtypes of Breast Cancer (Retracted Article)

被引:2
|
作者
Lin, Weixun [1 ]
Chen, Yaokun [1 ]
Ji, Zeqi [1 ]
Chen, Lingzhi [1 ]
Wu, Jinyao [1 ]
Chen, Yexi [1 ]
Li, Zhiyang [1 ]
机构
[1] Shantou Univ Med Coll, Hosp 2, Dept Thyroid Breast & Hernia Surg, Shantou 515041, Guangdong, Peoples R China
关键词
ELIGIBILITY CRITERIA; TRIAL ELIGIBILITY; AGE; STRATEGIES; ADJUVANT; THERAPY; STAGE; WOMEN; RACE;
D O I
10.1155/2022/6116658
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Patients with a previous cancer history (PCA) are routinely excluded from most clinical trials, which may limit the accuracy and universality of clinical trials. We aimed to explore the association between PCA and survival of patients with different molecular subtypes of breast cancer. Patients diagnosed with breast cancer from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2015 were included in this retrospective cohort study. The primary outcome was overall survival (OS), which was calculated from date of diagnosis to date of death or censor date during this period. The relationship between PCA and OS of patients with different molecular subtypes of breast cancer was analyzed by the Kaplan-Meier curves and multivariate Cox proportional-hazards model. A total of 35,640 primary breast cancer patients were included, and 2,038 (5.72%) patients had a PCA. Female genital system cancer (491 cases, 24.09%) was the largest proportion type of previous cancer, and HER2-positive (24,754 cases, 69.46%) breast cancer was the most common subtype. Patients with previous female genital/endocrine system cancer history and other cancers history were associated with a poorer OS in overall patients, and in patients with triple-negative and HER2-positive subtypes (P < 0.05). In patients with Luminal A and Luminal B subtypes, previous other cancers history was related to poor OS (P < 0.05), while female genital/endocrine system cancer history may not influence the OS (P > 0.05). Subgroup analyses presented that PCA was related to poor OS in patients aged 40-64 years and & GE;65 years (P < 0.05), while prognosis in patients aged 18-40 years may not be influenced by PCA (P > 0.05). The impact of PCA on the prognosis of breast cancer patients was related to molecular type, patient age, and type of PCA. In clinical trials of breast cancer, the exclusion criteria for PCA patients may be modified according to the above variables.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] Survival among breast cancer patients with a history of previous cancer.
    Pruitt, Sandi
    Zhu, Hong
    Gerber, David E.
    Heitjan, Daniel
    Maddineni, Bhumika
    Xiong, Danyi
    Halm, Ethan
    Murphy, Caitlin C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [22] RETRACTED: Effect of Narrative Nursing on Family Resilience and Psychosocial Adaptation of Middle-Aged Patients with Breast Cancer (Retracted Article)
    Jin, Xiaohong
    Liu, Xiaoman
    Xie, Huiwen
    Yu, Jie
    Gu, Dongmei
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [23] RETRACTED: Efficacy of accelerated partial breast irradiation as a neoadjuvant treatment for patients with breast cancer: A pilot study (Retracted Article)
    Sato, Kazuhiko
    Uematsu, Minoru
    Saito, Tsuyoshi
    Tsuda, Hitoshi
    Takeuchi, Hideki
    Shigekawa, Takashi
    Hiraide, Hoshio
    SURGERY, 2006, 139 (05) : 617 - 623
  • [24] RETRACTED: Effect of Immediate Breast Reconstruction after Standardized Breast Cancer Surgery on the Quality of Life of Patients: A Prospective Multicenter Study (Retracted Article)
    Zhang, Chao
    Jiang, Hongchuang
    JOURNAL OF HEALTHCARE ENGINEERING, 2021, 2021
  • [25] RETRACTED: Postoperative Adjuvant Chemoradiotherapy on the Survival of Stage III Gastric Cancer (Retracted Article)
    Li, Chao
    Shao, Shoupeng
    Sun, Yue
    Shen, Fujun
    Wang, Meijuan
    Wang, Hongsheng
    Wang, Chunbin
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [26] RETRACTED: A Ferroptosis-Related Gene Signature for Predicting Survival and Immunotherapy Effect in Renal Cancer (Retracted Article)
    Tong, Liang
    Yin, Zhao-fa
    Peng, Liang
    Li, Yu-ting
    Liu, Rong
    Cai, Jia-rong
    Kang, Le
    COMPUTATIONAL AND MATHEMATICAL METHODS IN MEDICINE, 2022, 2022
  • [27] RETRACTED: Effect of Different Hemodialysis Methods on Microbiota in Uremic Patients (Retracted Article)
    He, Haidong
    Xie, Yan
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [28] RETRACTED: Molecular Mechanism of Secondary Endocrine Resistance in Luminal Breast Cancer (Retracted Article)
    Wu, Minhua
    Ding, Jinhua
    Wen, Limu
    Zhou, Yuxin
    Wu, Weizhu
    BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [29] RETRACTED: Diagnosing breast cancer with an improved artificial immune recognition system (Retracted Article)
    Saybani, Mahmoud Reza
    Teh Ying Wah
    Aghabozorgi, Saeed Reza
    Shamshirband, Shahaboddin
    Kiah, Miss Laiha Mat
    Balas, Valentina Emilia
    SOFT COMPUTING, 2016, 20 (10) : 4069 - 4084
  • [30] RETRACTED: Functional analyses of microRNA-326 in breast cancer development (Retracted Article)
    Du, Ye
    Shen, Lishengnan
    Zhang, Wei
    Ding, Rongbo
    Li, Qian
    Li, Simin
    Zhang, Haipeng
    BIOSCIENCE REPORTS, 2019, 39